VISTAGEN THERAPEUTICS, INC. Receivables, Net, Current
VISTAGEN THERAPEUTICS, INC. (VTGN) had Receivables, Net, Current of $1.25 million as of 2016-12-31, per its 10-Q filed 2017-02-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:ReceivablesNetCurrent · last filed 2017-02-13
- 2016-12-31: Receivables, Net, Current $1.25M.
- 2016-03-31: Receivables, Net, Current $0.00.
- 2012-03-31: Receivables, Net, Current $106.20K.
- 2011-12-31: Receivables, Net, Current $7.78K.
| Period end | Receivables, Net, Current | Receivables, Net, Current as first filed |
|---|---|---|
| 2016-12-31 | $1.25M 10-Q · filed 2017-02-13 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-02-13 | |
| 2012-03-31 | $106.20K 10-K · filed 2013-07-18 | |
| 2011-12-31 | $7.78K 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $127.06K 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $148.53K 10-Q · filed 2011-08-22 | |
| 2011-03-31 | $42.20K 10-K · filed 2012-07-02 | $42.22K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |